<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02679404</url>
  </required_header>
  <id_info>
    <org_study_id>APR001</org_study_id>
    <nct_id>NCT02679404</nct_id>
  </id_info>
  <brief_title>Sorin Universal REgistry on Aortic Valve Replacement</brief_title>
  <acronym>SURE-AVR</acronym>
  <official_title>Sorin Universal REgistry on Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center, International, Prospective, Non comparative, Non randomized, Open label.

      5,000 patients to be enrolled approximately worldwide.

      The objective of this registry is to collect safety and clinical performance post market data
      related to the procedure and follow-up of the Sorin Group aortic valve devices in accordance
      with the Instructions for Use (IFU).

      This observational global registry is intended to collect data without requiring any
      deviation from the standard of care and IFU in each participating center. The participating
      centers shall include those patients that have provided their informed consent to participate
      in this registry in accordance with the local applicable regulations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SURE-AVR objective is to collect post market safety and performance data collected along the
      procedure and the relevant follow-up with Sorin Group aortic valve devices in accordance with
      the IFU to further evidence the safety and efficacy in a post-approval environment. All
      current and future Sorin Group aortic valve devices that have obtained CE-mark or other local
      regulatory and/or commercial approvals may be included in the registry. During the duration
      of the registry,other aortic valve replacement products or current devices might receive
      modifications and might become commercial available. This registry allows extensions for the
      inclusion of new products.

      This observational global registry is intended to collect data without requiring any
      deviation from the standard of care and IFU in each participating center. The participating
      centers shall include those patients that have provided their informed consent to participate
      in this registry following the local applicable regulations.

      The data collection shall be performed as per the local standard of care and without exposing
      the patient to any additional risk to the treatment (s)he would normally receive.

      The registry is an open-ended project:

        -  Inclusions phase: open-ended

        -  Follow-up phase: annually throughout 5 years (7 and 10 years are optional).

      The study shall be completed after the 10-year follow-up of the last patient.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">May 2029</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite rate of valve related major adverse events (MAEs)</measure>
    <time_frame>At 5 years follow-up</time_frame>
    <description>To evaluate the composite rate of site reported valve related MAE defined as death, stroke and/or re-intervention (involving surgery or any other invasive therapy) at 5 years follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural timings</measure>
    <time_frame>Intra-operative and at 30 days (average)</time_frame>
    <description>Cross clamp time, intensive care unit and total length of hospital stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>30 days (average)</time_frame>
    <description>The clinical success defined as a successful valve implantation without MAE at hospital discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of clinical status</measure>
    <time_frame>Annually through a 5-year follow-up, and 7 and 10-year follow-up in selected centers only.</time_frame>
    <description>The improvement of clinical status defined as an improvement of at least one scale of the New York Heart Association (NYHA) classification between pre-procedure and annually throughout the duration of the registry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic evaluation</measure>
    <time_frame>Annually through a 5-year follow-up, and 7 and 10-year follow-up in selected centers only.</time_frame>
    <description>Performance of the device in terms of hemodynamic behavior - Effective Orifice Area (cmÂ²), Ejection Fraction (%),Mean Aortic Gradient (mmHg), Peak Aortic Gradient (mmHg), LV mass (g) - throughout the duration of the registry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAE during the duration of the registry</measure>
    <time_frame>Annually through a 5-year follow-up, and 7 and 10-year follow-up in selected centers only.</time_frame>
    <description>All site reported MAE rates during the duration of the registry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of valve related MAE</measure>
    <time_frame>4-year, and 7 and 10-year follow-up in selected centers only</time_frame>
    <description>The composite rate of site reported valve-related MAE annually through a 4-year follow-up, and 7 and 10-year follow-up in selected centers only.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valve-related Serious Adverse Event (SAE)</measure>
    <time_frame>Annually through a 5-year follow-up, and 7 and 10-year follow-up in selected centers only.</time_frame>
    <description>Other site reported valve-related SAE such as, but not limited to, bleeding, thromboembolism, valve thrombosis, endocarditis, non structural dysfunction, structural valve deterioration annually through a 5-year follow-up, and 7 and 10-year follow-up in selected centers only.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients having received a Sorin Group aortic valve device in accordance with the IFU
        can be included in the registry. Other than the indication and the contra-indications
        specified in each IFU, there are no specific inclusion and exclusion criteria since this
        registry has the aim to include all patients following &quot;real life&quot;/standard of care
        practices at participating centers. All patients must provide written or oral informed
        consent to participate in the registry following the local regulations.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients must provide written or oral informed consent to participate in the
             registry depending on the local regulations.

          -  Patients having received a Sorin Group aortic valve device in accordance with the IFU

        Exclusion Criteria: NA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara Gaggianesi</last_name>
    <role>Study Director</role>
    <affiliation>Sorin Group Italia S.r.l.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Llorca</last_name>
    <phone>+33 622 677 190</phone>
    <email>anne.llorca@livanova.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gaia Giannicola</last_name>
    <phone>+393451174649</phone>
    <email>gaia.giannicola@livanova.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Melbourne Private Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alistair Royse</last_name>
      <email>Alistair.Royse@heartweb.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alistair Royse</last_name>
      <email>alistair.royse@heartweb.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Salzburg</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Steindl</last_name>
      <email>j.steindl@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCL St Luc</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU LiÃ¨ge</name>
      <address>
        <city>LiÃ¨ge</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHR Namur</name>
      <address>
        <city>Namur</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc D. Marnette</last_name>
      <email>jm@marnette.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Private cardiac center - Burgas</name>
      <address>
        <city>Burgas</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Petrov</last_name>
      <email>doctorpetrov@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foothill Medical Centre - Calgary, Alberta</name>
      <address>
        <city>Calgary</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Kent</last_name>
      <email>wdkent@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Marg Holland</last_name>
      <email>marg.holland@calgaryhealthregion.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Center of Cardiovascular Surgery and Transplantation Brno</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Zakova</last_name>
      <email>daniela.zakova@cktch.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IKEM - Prague</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Adamira</last_name>
      <email>maad@medicon.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadine Laborde</last_name>
      <email>nadine-everest@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Augustin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique la Protestante</name>
      <address>
        <city>Caluire</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Camilleri</last_name>
      <email>lcamilleri@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herve A. Corbineau</last_name>
      <email>Herve.Corbineau@chu-rennes.fr</email>
    </contact>
    <contact_backup>
      <last_name>RÃ©da Belhaj</last_name>
      <email>belhajreda@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nuremberg Hospital</name>
      <address>
        <city>Nuremberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo</name>
      <address>
        <city>Alessandria</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Mercogliano</last_name>
      <email>dmercogliano@ospedale.al.it</email>
    </contact>
    <contact_backup>
      <last_name>Gloria Demicheli</last_name>
      <email>gloria.demicheli@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Policlinico S.Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione Poliambulanza Istituto Ospedaliero</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Troise</last_name>
      <email>giovanni.troise@poliambulanza.it</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Messina</last_name>
      <email>antonio.messina@poliambulanza.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fondazione Toscana Gabriele Monasterio-Presidio Ospedaliero di Massa</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Solinas</last_name>
      <email>marco.solinas@ftgm.it</email>
    </contact>
    <contact_backup>
      <last_name>Alessandra Parlanti</last_name>
      <email>parlantialessandra@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Alamanni</last_name>
      <email>falamanni@ccfm.it</email>
    </contact>
    <contact_backup>
      <last_name>Veronika Myasoedova</last_name>
      <email>myika@yandex.ru</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Sant'Ambrogio</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mattia Glauber</last_name>
      <email>mattia.glauber@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Miceli</last_name>
      <email>antoniomiceli79@alice.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Ca' Foncello - Treviso</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elvio Polesel</last_name>
      <email>epolesel@ulss.tv.it</email>
    </contact>
    <contact_backup>
      <last_name>Gianluca Folesani</last_name>
      <email>gfolesani@ulss.tv.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria &quot;Ospedali Riuniti&quot; di Trieste</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aniello Pappalardo</last_name>
      <email>aniello.pappalardo@aots.sanita.fvg.it</email>
    </contact>
    <contact_backup>
      <last_name>Bernardo Benussi</last_name>
      <email>bernardo.benussi@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria &quot;S. Maria della Misericordia&quot; di Udine</name>
      <address>
        <city>Udine</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ugolino Livi</last_name>
      <email>livi.ugo@aoud.sanita.fvg.it</email>
    </contact>
    <contact_backup>
      <last_name>Enzo Mazzaro</last_name>
      <email>enzo.mazzaro@virgilio.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Amphia hospital Breda</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soon Jia Lin</last_name>
      <email>soon.jia.lin@singhealth.com.sg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vusch - Kosice</name>
      <address>
        <city>KoÅ¡ice</city>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Mistrikova</last_name>
      <email>lmistrikova@vusch.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blackpool Teaching Hospital</name>
      <address>
        <city>Blackpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Sussex County Hospital - Brighton</name>
      <address>
        <city>Brighton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Lewis</last_name>
      <email>Michael.Lewis@bsuh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Chukwuemeka</last_name>
      <email>Andrew.Chukwuemeka@imperial.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Max Baghai</last_name>
      <email>mbaghai@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brompton</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Asimakopoulos</last_name>
      <email>G.Asimakopoulos@rbht.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Singapore</country>
    <country>Slovakia</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2016</study_first_submitted>
  <study_first_submitted_qc>February 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biological aortic valves</keyword>
  <keyword>Mechanical aortic valves</keyword>
  <keyword>Aortic conduits</keyword>
  <keyword>Sutureless Aortic Valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

